CHC Healthcare Group

TWSE:4164 주식 보고서

시가총액: NT$7.0b

CHC Healthcare Group 미래 성장

Future 기준 확인 4/6

CHC Healthcare Group은 연간 수입과 매출이 각각 62.9%와 15.3% 증가할 것으로 예상되고 EPS는 연간 62.7%만큼 증가할 것으로 예상됩니다.

주요 정보

62.9%

수익 성장률

62.7%

EPS 성장률

Healthcare 수익 성장19.0%
매출 성장률15.3%
향후 자기자본 수익률n/a
애널리스트 커버리지

Low

마지막 업데이트23 Oct 2024

최근 미래 성장 업데이트

Recent updates

CHC Healthcare Group (TWSE:4164) Will Pay A Larger Dividend Than Last Year At NT$2

Jun 29
CHC Healthcare Group (TWSE:4164) Will Pay A Larger Dividend Than Last Year At NT$2

CHC Healthcare Group's (TWSE:4164) Dividend Will Be Increased To NT$2.01

Jun 15
CHC Healthcare Group's (TWSE:4164) Dividend Will Be Increased To NT$2.01

If You Had Bought CHC Healthcare Group's (TPE:4164) Shares Five Years Ago You Would Be Down 36%

Mar 08
If You Had Bought CHC Healthcare Group's (TPE:4164) Shares Five Years Ago You Would Be Down 36%

CHC Healthcare Group's (TPE:4164) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Feb 07
CHC Healthcare Group's (TPE:4164) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Should CHC Healthcare Group (TPE:4164) Be Part Of Your Dividend Portfolio?

Jan 21
Should CHC Healthcare Group (TPE:4164) Be Part Of Your Dividend Portfolio?

Is CHC Healthcare Group (TPE:4164) Likely To Turn Things Around?

Jan 06
Is CHC Healthcare Group (TPE:4164) Likely To Turn Things Around?

Is CHC Healthcare Group (TPE:4164) Using Too Much Debt?

Dec 22
Is CHC Healthcare Group (TPE:4164) Using Too Much Debt?

CHC Healthcare Group (TPE:4164) Share Prices Have Dropped 32% In The Last Five Years

Dec 07
CHC Healthcare Group (TPE:4164) Share Prices Have Dropped 32% In The Last Five Years

Are CHC Healthcare Group's (TPE:4164) Statutory Earnings A Good Guide To Its Underlying Profitability?

Nov 22
Are CHC Healthcare Group's (TPE:4164) Statutory Earnings A Good Guide To Its Underlying Profitability?

수익 및 매출 성장 예측

TWSE:4164 - 애널리스트의 미래 추정치 및 과거 재무 데이터 (TWD Millions )
날짜수익수익잉여 현금 흐름작전 현금평균 애널리스트 수
12/31/20254,620513N/AN/A1
12/31/20243,5751245611,0611
6/30/20243,807274416863N/A
3/31/20243,7343425801,232N/A
12/31/20233,877419387963N/A
9/30/20233,283302-120480N/A
6/30/20233,362360-148534N/A
3/31/20233,168376-331321N/A
12/31/20222,974357-26657N/A
9/30/20222,992409197873N/A
6/30/20222,65437562676N/A
3/31/20222,405337124717N/A
12/31/20212,440382179693N/A
9/30/20212,09829443795N/A
6/30/20212,451383177913N/A
3/31/20212,641400280898N/A
12/31/20202,555366195916N/A
9/30/20202,6303967471,245N/A
6/30/20202,7413938361,245N/A
3/31/20202,8754071,0151,401N/A
12/31/20192,9503958711,215N/A
9/30/20193,003402121444N/A
6/30/20192,79134739357N/A
3/31/20192,733366-296147N/A
12/31/20182,507323-33338N/A
9/30/20182,4633733391N/A
6/30/20182,193-3977454N/A
3/31/20181,948-142N/A420N/A
12/31/20172,117-87N/A294N/A
9/30/20172,307240N/A512N/A
6/30/20172,242232N/A445N/A
3/31/20172,418227N/A735N/A
12/31/20162,205159N/A845N/A
9/30/20162,165133N/A628N/A
6/30/20162,366185N/A786N/A
3/31/20162,450271N/A782N/A
12/31/20152,395227N/A576N/A
9/30/20152,363236N/A732N/A
6/30/20152,176205N/A612N/A
3/31/20151,974189N/A436N/A
12/31/20142,091266N/A634N/A
9/30/20142,000242N/A738N/A
6/30/20142,240326N/A596N/A
3/31/20142,117328N/A673N/A
12/31/20132,063297N/A867N/A

애널리스트 미래 성장 예측

수입 대 저축률: 4164 의 연간 예상 수익 증가율( 62.9% )이 saving rate( 1% 보다 높습니다. ).

수익 vs 시장: 4164 의 연간 수익( 62.9% ) TW 시장( 19% 보다 빠르게 성장할 것으로 예상됩니다. 19% 연간).

고성장 수익: 4164 의 수입은 향후 3년 동안 상당히 증가할 것으로 예상됩니다.

수익 대 시장: 4164 의 수익(연간 15.3% ) TW 시장( 12.3% 보다 빠르게 성장할 것으로 예상됩니다. 12.3% 연간).

고성장 수익: 4164 의 수익(연간 15.3% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.

주당 순이익 성장 예측

미래 자기자본 수익률

미래 ROE: 4164 의 자기자본수익률이 3년 내에 높을 것으로 예상되는지 판단하기에는 데이터가 부족합니다.

성장 기업 발견

7D

1Y

7D

1Y

7D

1Y